ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Catty, in the near term if they are interested in Opiant, it will most likely be a distribution deal. As Jeff said their primary focus is the Corti drugs.

Art has stated that his interest is in acquiring an injectables manufacturing company or facility. This aligns well with bringing Corti manufacturing in-house. Injectables were Art's specialty, so I am certain he will be able to find a facility/company without over paying.

When Corti was acquired it was a $1 billion drug with a market penetration of 10,000 patients out of a potential 4,000,000. The key for Art will be finding an optimal price point for Corti to get broader coverage.

On a side note, if Abbvie is still interested in Libigel, Allergan has their vote on the merger October 14th. Globally, there is an obvious move towards advancing testosterone in a responsible manner and the 10 societies who support the global position statement have given whoever takes the gauntlet a road map for potential future indications, contingent on positive outcomes in future trials.

JMHO

AbbVie is leading a phase 4 trial "Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study"

Trial

Hard to believe AbbVie would not be interested a similar trial for women by getting Libigel approved for HSDD with the pre-marketing safety data they have and then commence a phase 4 trial for women once Libigel is marketed.